Submitted by Anonymous (not verified) on 3 November 2026 - 16:26
Human medicines European public assessment report (EPAR): Vlustozik (previously Ibuprofen Gen.Orph), ibuprofen, Date of authorisation: 16/02/2024, Revision: 5, Status: Authorised
Source:
